$9.96
-0.20-1.97%
At close: -
$9.96
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
NeoGenomics Stock Guidance | NASDAQ:NEO | Benzinga
NeoGenomics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/18/2025 | NEO | NeoGenomics | FY | 2025 | $0.15 | $0.19 | $0.20 | $735.00M | $745.00M | $735.01M | Get Alert |
| 01/15/2025 | NEO | NeoGenomics | FY | 2025 | — | — | — | $735.00M | $745.00M | $727.90M | Get Alert |
| 01/15/2025 | NEO | NeoGenomics | FY | 2024 | — | — | — | $661.00M | $661.00M | $662.00M | Get Alert |
| 01/10/2025 | NEO | NeoGenomics | FY | 2024 | $0.08 | $0.10 | $0.10 | $655.00M | $667.00M | $662.00M | Get Alert |
| 11/05/2024 | NEO | NeoGenomics | FY | 2024 | $0.08 | $0.10 | $0.06 | $655.00M | $667.00M | $661.68M | Get Alert |
| 07/29/2024 | NEO | NeoGenomics | FY | 2024 | $0.02 | $0.07 | $0.02 | $655.00M | $667.00M | $655.25M | Get Alert |
| 04/30/2024 | NEO | NeoGenomics | FY | 2024 | $0.00 | $0.04 | -$0.01 | $650.00M | $660.00M | $654.56M | Get Alert |
| 02/20/2024 | NEO | NeoGenomics | Q1 | 2024 | — | — | — | $148.00M | $151.00M | $149.38M | Get Alert |
| 02/20/2024 | NEO | NeoGenomics | FY | 2024 | — | — | — | $650.00M | $660.00M | $632.43M | Get Alert |
| 11/06/2023 | NEO | NeoGenomics | FY | 2023 | -$0.18 | -$0.15 | -$0.28 | $585.00M | $592.00M | $573.19M | Get Alert |
| 08/08/2023 | NEO | NeoGenomics | FY | 2023 | -$0.28 | -$0.23 | -$0.36 | $565.00M | $575.00M | $562.42M | Get Alert |
| 05/08/2023 | NEO | NeoGenomics | FY | 2023 | -$0.36 | -$0.30 | -$0.42 | $555.00M | $565.00M | $549.82M | Get Alert |
| 04/04/2023 | NEO | NeoGenomics | FY | 2023 | -$0.38 | -$0.32 | -$0.44 | $545.00M | $555.00M | $549.97M | Get Alert |
| 02/23/2023 | NEO | NeoGenomics | FY | 2023 | -$0.38 | -$0.32 | -$0.53 | $545.00M | $555.00M | $535.08M | Get Alert |
| 03/28/2022 | NEO | NeoGenomics | Q1 | 2022 | — | — | — | — | $118.00M | $119.16M | Get Alert |
| 02/23/2022 | NEO | NeoGenomics | FY | 2022 | -$0.65 | -$0.53 | -$0.53 | $530.00M | $550.00M | $550.74M | Get Alert |
| 11/04/2021 | NEO | NeoGenomics | FY | 2021 | -$0.29 | -$0.25 | -$0.21 | $482.50M | $487.50M | $497.53M | Get Alert |
| 08/06/2021 | NEO | NeoGenomics | FY | 2021 | -$0.27 | -$0.23 | -$0.21 | $490.00M | $510.00M | $500.22M | Get Alert |
| 05/05/2021 | NEO | NeoGenomics | FY | 2021 | -$0.27 | -$0.23 | $0.20 | $490.00M | $510.00M | $498.21M | Get Alert |
FAQ
What is the most recent guidance for NeoGenomics (NEO)?
The most recent guidance for NeoGenomics (NEO) was reported on February 18, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $0.15 to $0.19, compared to the estimated EPS of $0.20. Additionally, NeoGenomics forecasted revenue between $0.74B and $0.75B for the quarter.
Browse guidance and forecast on all stocks.